|
TXNL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.741600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.249000E-01 |
| Normal-vs-Stage2 |
5.924000E-01 |
| Normal-vs-Stage3 |
6.620000E-02 |
| Normal-vs-Stage4 |
7.796200E-01 |
| Stage1-vs-Stage2 |
6.141600E-01 |
| Stage1-vs-Stage3 |
4.191600E-02 |
| Stage1-vs-Stage4 |
7.085400E-01 |
| Stage2-vs-Stage3 |
1.378970E-01 |
| Stage2-vs-Stage4 |
5.037600E-01 |
| Stage3-vs-Stage4 |
2.060200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.177000E-01 |
| Normal-vs-AfricanAmerican |
1.840390E-01 |
| Normal-vs-Asian |
2.297400E-03 |
| Caucasian-vs-AfricanAmerican |
2.104600E-01 |
| Caucasian-vs-Asian |
4.228400E-02 |
| AfricanAmerican-vs-Asian |
9.481900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.340800E-01 |
| Normal-vs-Female |
9.846600E-01 |
| Male-vs-Female |
5.152600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.623200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.836200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.233800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.391400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.582200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.347800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.541200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.880600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.155400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.139000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.254400E-01 |
| Normal-vs-Grade 2 |
4.062800E-01 |
| Normal-vs-Grade 3 |
2.811800E-01 |
| Normal-vs-Grade 4 |
1.127740E-02 |
| Grade 1-vs-Grade 2 |
7.205200E-01 |
| Grade 1-vs-Grade 3 |
6.240400E-01 |
| Grade 1-vs-Grade 4 |
1.756230E-01 |
| Grade 2-vs-Grade 3 |
4.611700E-02 |
| Grade 2-vs-Grade 4 |
2.839900E-03 |
| Grade 3-vs-Grade 4 |
7.586400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.395620E-01 |
| Normal-vs-ccB subtype |
1.503220E-01 |
| ccA subtype-vs-ccB subtype |
3.619000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.920600E-01 |
| Normal-vs-N1 |
9.871400E-01 |
| N0-vs-N1 |
8.045400E-01 |
|
|
